the first medically useful tumor necrosis factor antagonist. You have full access to this article via your institution. The isolation and identification of the TNF and lymphotoxin proteins and ...

Given the need to keep his gastrointestinal symptoms under control, he was given adalimumab, a recombinant human IgG1 monoclonal TNF antagonist, starting with an induction course of 160 mg ...

2010;5(1):101-115. In a 6-month observational, multinational study, patients with AS had experienced improvement in health-related quality of life by TNF-α antagonist use (infliximab and ...

Tumor necrosis factor (TNF)-alpha, a proinflammatory cytokine, has been implicated in the pathogenesis of AD. Objective: To investigate the use of a biologic TNF-alpha inhibitor, etanercept was ...

but the integrin receptor antagonist vedolizumab slightly edged out the tumor necrosis factor (TNF) blocker in some areas, according to a real-world dataset. At 52 weeks, there was no significant ...